Detalhe da pesquisa
1.
An analysis of diversity within academic urology leadership.
Can J Urol
; 29(4): 11204-11208, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969723
2.
Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.
J Urol
; 180(3): 1030-2; discussion 1032-3, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18639298
3.
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
N Engl J Med
; 349(25): 2387-98, 2003 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-14681504
4.
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
Urol Oncol
; 25(4): 291-7, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17628294
5.
Surrogate marker for predicting the virus binding of urogenital cancer cells during adenovirus-based gene therapy.
Biotechniques
; 35(1): 186-90, 192-4, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12866420
6.
Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.
Eur Urol
; 62(6): 953-61, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22652152
7.
Biopsy misidentification identified by DNA profiling in a large multicenter trial.
J Clin Oncol
; 29(13): 1744-9, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21444877
8.
Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
J Clin Oncol
; 25(4): 349-55, 2007 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17264329
9.
Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
J Urol
; 175(1): 217-20; discussion 220-1, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16406915
10.
Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.
J Urol
; 175(4): 1422-6; discussion 1426-7, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16516013
11.
Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.
Prostate
; 63(3): 299-308, 2005 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15611997
12.
Factors influencing the outcomes of penile prosthesis surgery at a teaching institution.
Urology
; 62(5): 918-21, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14624920
13.
The effect of combined androgen ablation on the expression of alpha1A-adrenergic receptor in the human prostate.
Prostate
; 60(4): 310-6, 2004 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15264242
14.
The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2.
J Biol Chem
; 277(15): 12622-31, 2002 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-11812785
15.
Heterogeneity of 5 alpha-reductase gene expression in benign prostatic hyperplasia.
J Urol
; 169(2): 575-9, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12544310
16.
Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.
BJU Int
; 94(1): 42-6, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15217428
17.
Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence.
Cancer
; 94(3): 690-9, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11857301
18.
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.
J Urol
; 171(6 Pt 1): 2209-14, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15126787
19.
Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.
Control Clin Trials
; 24(2): 224-43, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12689743
20.
Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.
Eur Urol
; 42(1): 1-6, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12121721